Hospitalizations for asthma in an urban population: 1995-1999

Annals of Allergy, Asthma and Immunology

Volumn 103, Issue 2, 2009, Pages 128-133

  Lang, David M ^a   Polansky, Marcia ^b   Sherman, Michael S ^c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b DREXEL UNIVERSITY   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CROMOGLYCATE DISODIUM; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LONG ACTING DRUG; NEDOCROMIL; SALMETEROL; SHORT ACTING DRUG; THEOPHYLLINE;

ADOLESCENT; ADULT; AFRICAN AMERICAN; ARTICLE; ASTHMA; CAUCASIAN; CHILD; DEMOGRAPHY; DISEASE EXACERBATION; FEMALE; HOSPITALIZATION; HUMAN; LOWEST INCOME GROUP; MALE; MORBIDITY; POVERTY; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; UNITED STATES; URBAN POPULATION;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-AGONISTS; ADULT; AFRICAN AMERICANS; AGE FACTORS; ASTHMA; CHILD; CHILD, PRESCHOOL; CHOLINERGIC ANTAGONISTS; CHROMONES; DRUG PRESCRIPTIONS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HOSPITALIZATION; HUMANS; LEUKOTRIENE ANTAGONISTS; MALE; MIDDLE AGED; PHILADELPHIA; POVERTY; RISK FACTORS; THEOPHYLLINE; URBAN POPULATION; YOUNG ADULT;

EID: 68249109354     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60165-2     Document Type: Article

References (26)

1. Moorman JE, Rudd RA, Johnson CA, et al. National Surveillance for asthma - United States, 1980-2004. MMWR Surveill Summ. 2007;56: 1-54.
2. Sullivan SD. The burden of uncontrolled asthma on the U.S. health care system. Manag Care. 2005;14(suppl):4-7.
3. Expert Panel Report 3 (EPR3): guidelines for the diagnosis and management of asthma. http://www.nhlbi.nih.gov/guidelines/asthma/ asthgdln.htm. Accessed August 31, 2007.
4. Suissa S, Ernst P, Kezouh A. Regular use of inhaled corticosteroids and the long term prevention of hospitalization for asthma. Thorax. 2002; 57:880-884. (Pubitemid 35178613)
5. Adams RJ, Fuhlbrigge A, Finkelstein J, et al. Impact of inhaled antiinflammatory therapy on hospitalization and emergency department visits for children with asthma. Pediatrics. 2001;107:706-711. (Pubitemid 32268455)
6. Rea HH, Scragg R, Jackson R, Beaglehole R, Fenwick J, Sutherland DCA. Case-control study of deaths from asthma. Thorax. 1986;41: 833-839.
7. Carr W, Zeitel L, Weiss K. Variations in asthma hospitalizations and deaths in New York City. Am J Public Health. 1992;82:59-65.
8. Lang DM, Polansky M. Patterns of asthma mortality in Philadelphia: 1969-1991. N Engl J Med. 1994;331:1542-1547.
9. Nelson H, Weiss S, Bleecker E, Yancey S, Dorinsky P. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest. 2006;129:15-26. (Pubitemid 43265239)
10. Wechsler M, Israel E. How pharmacogenetics will play a role in the management of asthma. Am J Respir Crit Care Med. 2005;172:12-18. (Pubitemid 40923310)
11. Wechsler M, Lehman E, Lazarus S, et al. β-Adrenergic receptor polymorphisms and response to salmeterol. Am J Respir Crit Care Med. 2006;173:519-526.
12. Salpeter SR, Buckley NS, Ormiston TM, Salpeter EE. Meta-analysis: effect of long acting β-agonists on severe asthma exacerbations and asthma-related deaths. Ann Intern Med. 2006;144:904-912.
13. National Asthma Education and Prevention Program. Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Heart, Lung, and Blood Institute; 1997. NIH publication 97-4051.
14. Vital Statistics Report: 1990. Philadelphia, PA: Philadelphia Department of Public Health; 1990.
15. Poverty in the United States: 1992. Washington, DC: US Bureau of the Census; 1993. Series P-60-185.
16. Kleinbaum DG, Kupper LL, Nizam A, Muller KE. Applied Regression Analysis and Other Multivariable Methods. 4th ed. Belmont, CA: Duxbury Press; 2008.
17. Schatz M, Nakahiro R, Crawford W, Mendoza G, Mosen D, Stibolt T. Asthma quality of care markers using administrative data. Chest. 2005; 128:1968-1973. (Pubitemid 41507529)
18. Ibrahim SA, Whittle J, Bean-Mayberry B, Kelley ME, Good C, Conigliaro J. Racial/ethnic variations in physician recommendations for cardiac revascularization. Am J Public Health. 2003;93:1689-1693.
19. Schulman KA, Berlin JA, Harless W, et al. The effect of race and sex on physicians' recommendations for cardiac catheterization. N Engl J Med. 1999;340:618-626. (Pubitemid 29093722)
20. Lozano P, Connell FA, Koepsell TD. Use of health services by African- American children with asthma on Medicaid. JAMA. 1995;274: 469-473.
21. Zoratti EM, Havstad S, Rodriguez J, Robens-Paradise Y, Lafata JE, McCarthy BD. Health care service use by African-Americans and Caucasians with asthma in a managed care setting. Am J Respir Crit Care Med. 1998;158:371-377. (Pubitemid 28378161)
22. Delamater AM, Albrecht BA, Postellon DC. Gutai JP. Racial differences in metabolic control of children and adolescents with type I diabetes mellitus. Diabetes Care. 1991;14:20-25.
23. Pichert J, Briscoe VJ. A questionnaire for assessing barriers to health care utilization. Diabetes Educ. 1997;23:181-191. (Pubitemid 127454656)
24. Centers for Disease Control and Prevention. Health disparities experienced by black or African Americans-United States. MMWR Morb Mortal Wkly Rep. 2005;54:1-3.
25. Joseph CLM, Williams LK, Ownby DR, Saltzgaber J, Johnson CC. Applying epidemiologic concepts of primary, secondary, and tertiary prevention to the elimination of racial disparities in asthma. J Allergy Clin Immunol. 2006;117:233-240. (Pubitemid 43190131)
26. Pearce N. The ecologic fallacy strikes back. J Epidemiol Community Health. 2000;54:326-327.